Summary

Persistence Market Research has recently released a comprehensive report on the global Membrane Oxygenators Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Membrane Oxygenators Market Size (2025E): US$ 135.0 Million
• Projected Market Value (2032F): US$ 152.9 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 1.8%

Membrane Oxygenators Market - Report Scope:

The membrane oxygenators market comprises advanced medical devices used to facilitate gas exchange during cardiopulmonary bypass procedures and extracorporeal life support (ECLS). These devices function as artificial lungs by oxygenating blood and removing carbon dioxide outside the body, making them critical in cardiac surgeries, respiratory support, and transplantation procedures. Growing prevalence of cardiovascular and respiratory disorders, increasing demand for extracorporeal membrane oxygenation (ECMO) therapies, and continuous technological advancements in oxygenator design are contributing to the development of the global membrane oxygenators market.

Market Growth Drivers:

The growth of the global membrane oxygenators market is primarily driven by the increasing incidence of cardiovascular diseases and respiratory disorders worldwide, leading to a greater number of surgical interventions and extracorporeal life support procedures. Rising adoption of ECMO systems in critical care settings, especially for patients suffering from severe respiratory failure, has significantly increased demand for membrane oxygenators. Advancements in biocompatible materials, improved gas exchange efficiency, and enhanced patient safety have further supported market growth. Additionally, growing healthcare expenditure and expanding access to advanced cardiac care facilities are contributing to the increased utilization of membrane oxygenators across healthcare institutions.

Market Restraints:

Despite its importance in critical care and surgical applications, the membrane oxygenators market faces several challenges. The high cost associated with membrane oxygenation systems and ECMO procedures can limit adoption, particularly in developing regions with constrained healthcare budgets. The need for specialized healthcare professionals and intensive patient monitoring during oxygenation procedures adds to operational complexity. Furthermore, risks associated with complications such as thrombosis, bleeding, and infections during extracorporeal circulation may hinder broader acceptance and utilization of membrane oxygenator technologies.

Market Opportunities:

The membrane oxygenators market offers promising opportunities through continuous innovation in oxygenator technologies and expanding applications of extracorporeal life support systems. Growing investments in critical care infrastructure and increasing awareness regarding advanced respiratory support therapies are expected to create new growth avenues. Emerging economies are witnessing improvements in healthcare facilities and access to specialized treatments, which could support greater adoption of membrane oxygenators. Moreover, ongoing research focused on enhancing oxygenator efficiency, reducing complications, and developing portable ECMO systems is expected to generate significant opportunities for manufacturers during the forecast period.

Key Questions Answered in the Report:

• What are the primary factors driving the global membrane oxygenators market's growth?
• Which regions and market segments are experiencing the highest demand for membrane oxygenators?
• How are technological advancements in extracorporeal life support systems influencing market dynamics?
• Who are the key players in the membrane oxygenators market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future projections for the global membrane oxygenators market?

Competitive Intelligence and Business Strategy:

Leading companies in the global membrane oxygenators market are focusing on technological advancements, product innovation, and strategic collaborations to strengthen their market presence. Manufacturers are investing in research and development activities aimed at improving oxygenator efficiency, biocompatibility, and patient safety. Strategic partnerships with hospitals, research institutions, and healthcare providers are enabling companies to expand their customer base and enhance product adoption. Additionally, efforts to develop next-generation ECMO systems and portable oxygenation solutions are helping market participants differentiate their offerings and maintain a competitive advantage.

Companies Covered in This Report:

• Medtronic PLC
• Getinge AB
• Terumo Corporation
• Fresenius Medical Care AG & Co. KGaA
• LivaNova PLC
• Nipro Corporation
• Asahi Kasei Medical Co., Ltd.
• Xenios AG
• Nikkiso Co., Ltd.
• Eurosets S.r.l.
• Drägerwerk AG & Co. KGaA
• Senko Medical Instrument Mfg. Co., Ltd.
• Beijing Aeonmed Co., Ltd.
• Braile Biomédica

Market Segmentation

By Product Type

• Hollow Fiber
• Flat Sheet (Plate)
• Microfluidic
• Artificial Lung Modules
• Others

By Age Group

• Neonates
• Pediatrics
• Adults

By Application

• Cardiac
• Respiratory
• Extracorporeal Life Support
• Transplantation
• Others

By Region

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Membrane Oxygenators Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-economic Factors
2.3.1. Global Sectoral Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Tool Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
4. Price Analysis, 2024A
4.1. Key Highlights
4.2. Key Factors Impacting Deployment Costs
4.3. Pricing Analysis, By Product Type
5. Global Membrane Oxygenators Market Outlook
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025 - 2032
5.3. Global Membrane Oxygenators Market Outlook: Product Type
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product Type, 2019 - 2024
5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
5.3.3.1. Hollow Fiber
5.3.3.2. Flat Sheet (Plate)
5.3.3.3. Microfluidic
5.3.3.4. Artificial Lung Modules
5.3.3.5. Others
5.3.4. Market Attractiveness Analysis: Product Type
5.4. Global Membrane Oxygenators Market Outlook: Age Group
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Mn) Analysis, By Age Group, 2019 - 2024
5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025 - 2032
5.4.3.1. Neonates
5.4.3.2. Pediatrics
5.4.3.3. Adults
5.4.4. Market Attractiveness Analysis: Age Group
5.5. Global Membrane Oxygenators Market Outlook: Application
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
5.5.3.1. Cardiac
5.5.3.2. Respiratory
5.5.3.3. Extracorporeal Life Support
5.5.3.4. Transplantation
5.5.3.5. Others
5.5.4. Market Attractiveness Analysis: Application
6. Global Membrane Oxygenators Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019 - 2024
6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Membrane Oxygenators Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
7.2.1. By Country
7.2.2. By Product Type
7.2.3. By Age Group
7.2.4. By Application
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
7.3.1. U.S.
7.3.2. Canada
7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
7.4.1. Hollow Fiber
7.4.2. Flat Sheet (Plate)
7.4.3. Microfluidic
7.4.4. Artificial Lung Modules
7.4.5. Others
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025 - 2032
7.5.1. Neonates
7.5.2. Pediatrics
7.5.3. Adults
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
7.6.1. Cardiac
7.6.2. Respiratory
7.6.3. Extracorporeal Life Support
7.6.4. Transplantation
7.6.5. Others
7.7. Market Attractiveness Analysis
8. Europe Membrane Oxygenators Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
8.2.1. By Country
8.2.2. By Product Type
8.2.3. By Age Group
8.2.4. Application
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Türkiye
8.3.8. Rest of Europe
8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
8.4.1. Hollow Fiber
8.4.2. Flat Sheet (Plate)
8.4.3. Microfluidic
8.4.4. Artificial Lung Modules
8.4.5. Others
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025 - 2032
8.5.1. Neonates
8.5.2. Pediatrics
8.5.3. Adults
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
8.6.1. Cardiac
8.6.2. Respiratory
8.6.3. Extracorporeal Life Support
8.6.4. Transplantation
8.6.5. Others
8.7. Market Attractiveness Analysis
9. East Asia Membrane Oxygenators Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
9.2.1. By Country
9.2.2. By Product Type
9.2.3. By Age Group
9.2.4. By Application
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
9.4.1. Hollow Fiber
9.4.2. Flat Sheet (Plate)
9.4.3. Microfluidic
9.4.4. Artificial Lung Modules
9.4.5. Others
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025 - 2032
9.5.1. Neonates
9.5.2. Pediatrics
9.5.3. Adults
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
9.6.1. Cardiac
9.6.2. Respiratory
9.6.3. Extracorporeal Life Support
9.6.4. Transplantation
9.6.5. Others
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Membrane Oxygenators Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
10.2.1. By Country
10.2.2. By Product Type
10.2.3. By Age Group
10.2.4. By Application
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
10.4.1. Hollow Fiber
10.4.2. Flat Sheet (Plate)
10.4.3. Microfluidic
10.4.4. Artificial Lung Modules
10.4.5. Others
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025 - 2032
10.5.1. Neonates
10.5.2. Pediatrics
10.5.3. Adults
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
10.6.1. Cardiac
10.6.2. Respiratory
10.6.3. Extracorporeal Life Support
10.6.4. Transplantation
10.6.5. Others
10.7. Market Attractiveness Analysis
11. Latin America Membrane Oxygenators Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
11.2.1. By Country
11.2.2. By Product Type
11.2.3. By Age Group
11.2.4. By Application
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
11.4.1. Hollow Fiber
11.4.2. Flat Sheet (Plate)
11.4.3. Microfluidic
11.4.4. Artificial Lung Modules
11.4.5. Others
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025 - 2032
11.5.1. Neonates
11.5.2. Pediatrics
11.5.3. Adults
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
11.6.1. Cardiac
11.6.2. Respiratory
11.6.3. Extracorporeal Life Support
11.6.4. Transplantation
11.6.5. Others
11.7. Market Attractiveness Analysis
12. Middle East & Africa Membrane Oxygenators Market Outlook
12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
12.2.1. By Country
12.2.2. By Product Type
12.2.3. By Age Group
12.2.4. By Application
12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
12.4.1. Hollow Fiber
12.4.2. Flat Sheet (Plate)
12.4.3. Microfluidic
12.4.4. Artificial Lung Modules
12.4.5. Others
12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025 - 2032
12.5.1. Neonates
12.5.2. Pediatrics
12.5.3. Adults
12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
12.6.1. Cardiac
12.6.2. Respiratory
12.6.3. Extracorporeal Life Support
12.6.4. Transplantation
12.6.5. Others
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Medtronic PLC
13.3.1.1. Overview
13.3.1.2. Segments and Deployments
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Getinge AB
13.3.3. Terumo Corporation
13.3.4. Fresenius Medical Care AG & Co. KGaA
13.3.5. LivaNova PLC
13.3.6. Nipro Corporatio
13.3.7. Asahi Kasei Medical Co., Ltd.
13.3.8. Xenios AG
13.3.9. Nikkiso Co., Ltd.
13.3.10. Eurosets S.r.l.
13.3.11. Drägerwerk AG & Co. KGaA
13.3.12. Senko Medical Instrument Mfg. Co., Ltd.
13.3.13. Beijing Aeonmed Co., Ltd.
13.3.14. Braile Biomédica
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations